Literature DB >> 21698778

Early drug discovery and the rise of pharmaceutical chemistry.

Alan Wayne Jones1.   

Abstract

Studies in the field of forensic pharmacology and toxicology would not be complete without some knowledge of the history of drug discovery, the various personalities involved, and the events leading to the development and introduction of new therapeutic agents. The first medicinal drugs came from natural sources and existed in the form of herbs, plants, roots, vines and fungi. Until the mid-nineteenth century nature's pharmaceuticals were all that were available to relieve man's pain and suffering. The first synthetic drug, chloral hydrate, was discovered in 1869 and introduced as a sedative-hypnotic; it is still available today in some countries. The first pharmaceutical companies were spin-offs from the textiles and synthetic dye industry and owe much to the rich source of organic chemicals derived from the distillation of coal (coal-tar). The first analgesics and antipyretics, exemplified by phenacetin and acetanilide, were simple chemical derivatives of aniline and p-nitrophenol, both of which were byproducts from coal-tar. An extract from the bark of the white willow tree had been used for centuries to treat various fevers and inflammation. The active principle in white willow, salicin or salicylic acid, had a bitter taste and irritated the gastric mucosa, but a simple chemical modification was much more palatable. This was acetylsalicylic acid, better known as Aspirin®, the first blockbuster drug. At the start of the twentieth century, the first of the barbiturate family of drugs entered the pharmacopoeia and the rest, as they say, is history.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21698778     DOI: 10.1002/dta.301

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  8 in total

Review 1.  Synthetic Chemical Trade as a Potential Driver of Global Health Disparities and Data Gaps on Synthetic Chemicals in Vulnerable Populations.

Authors:  Dina Goodman; Nicholas Arisco; Lindsay M Jaacks
Journal:  Curr Environ Health Rep       Date:  2020-03

2.  Advanced targeted nanomedicine.

Authors:  Mohan C Pereira; Mohan C M Arachchige; Yana K Reshetnyak; Oleg A Andreev
Journal:  J Biotechnol       Date:  2015-01-20       Impact factor: 3.307

3.  Regulatory Considerations for Gene Therapy Products in the US, EU, and Japan.

Authors:  Celine-Lea Halioua-Haubold; James G Peyer; James A Smith; Zeeshaan Arshad; Matthew Scholz; David A Brindley; Robert E MacLaren
Journal:  Yale J Biol Med       Date:  2017-12-19

Review 4.  Current Screening Methodologies in Drug Discovery for Selected Human Diseases.

Authors:  Olga Maria Lage; María C Ramos; Rita Calisto; Eduarda Almeida; Vitor Vasconcelos; Francisca Vicente
Journal:  Mar Drugs       Date:  2018-08-14       Impact factor: 5.118

5.  Induction of Secretagogue Independent Gastric Acid Secretion via a Novel Aspirin-Activated Pathway.

Authors:  Alice Miriam Kitay; Florentina Sophie Ferstl; Alexander Link; John Peter Geibel
Journal:  Front Physiol       Date:  2019-10-10       Impact factor: 4.566

Review 6.  An Overview of Nanotechnologies for Drug Delivery to the Brain.

Authors:  Ahsan Ayub; Shawn Wettig
Journal:  Pharmaceutics       Date:  2022-01-19       Impact factor: 6.321

Review 7.  Plant and fungi derived analgesic natural products targeting voltage-gated sodium and calcium channels.

Authors:  Aida Calderon-Rivera; Santiago Loya-Lopez; Kimberly Gomez; Rajesh Khanna
Journal:  Channels (Austin)       Date:  2022-12       Impact factor: 3.493

8.  Beyond plant defense: insights on the potential of salicylic and methylsalicylic acid to contain growth of the phytopathogen Botrytis cinerea.

Authors:  Cindy Dieryckx; Vanessa Gaudin; Jean-William Dupuy; Marc Bonneu; Vincent Girard; Dominique Job
Journal:  Front Plant Sci       Date:  2015-10-16       Impact factor: 5.753

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.